InvestorsHub Logo
Followers 27
Posts 2742
Boards Moderated 0
Alias Born 03/17/2017

Re: None

Monday, 09/17/2018 10:55:56 PM

Monday, September 17, 2018 10:55:56 PM

Post# of 796
NCCN Guidelines have been updated with AZEDRA, the first and only FDA approved treatment of patients 12 and older with iobenguane scan positive, locally unresectable and metastatic pheochromocytoma or paraganglioma.

That was quite fast and probably kicked off today's reversal - besides being traded 34% below offering price.

https://ir.progenics.com/news-releases/news-release-details/progenics-announces-addition-azedrar-iobenguane-i-131-national